References
- Bardhan K D. Br Med J 1980; 281: 20–22
- Bardhan K D, Cole D S, Hawkins B W, Sharpe P C. Gut 1980; 21: A898
- Gudmand-Højer E, Birger-Jensen K, Krag E, Rask-Madsen J, Rahbek J. Br Med J 1978; 1: 1095–1097
- Piper D W, Shinners J, Greig M, Thomas J, Waller S L. Gut 1978; 19: 419–424
- Bardhan K D, Saul D M, Edwards J L, Smith P M, Haggie S J, Wyllie J H, Duthie H L, Fussey I V. Gut 1979; 20: 158–162
- Hunt R H, Walt R P, Trotman I F, Colley S, . The clinical use of ranitidine, J J Misiewicz, K G Wormsley, et al. The Medicine Publishing Foundation, OxfordUK 1982
- Bianchi-Porro G, Burland W L, Hawkins B W, Petrillo M. H2-receptor antagonists in peptic ulcer disease and progress in histamine research, A Torsoli, P E Lucchelli, R W Brimblecombe. Excerpta Medica, Amsterdam, Oxford, Princeton 1980; 91–101
- Bodemar G, Walan A. Lancet 1978; 2: 403–407
- Gledhill T, Howard O, Buck M, Paul A, Hunt R H. Gut 1983; 24: 497
- Delattre M, Dickson B. Lancet 1984; 1: 625
- Ireland A, Pear P, Colin-Jones D G, Golding P L, et al. Lancet 1984; 2: 274–276
- Horisberger B. Economic and medical evaluation of health care technologies, A J Culyer, B Horisberger, 1983
- Jönsson B. Economic and medical evaluation of health care technologies, A J Culyer, B Horisberger, 1983
- Gear M WL. Br Med J 1983; 286: 98–99
- Gray G R, Smith I S, McWhinnie D, Gillespie G. Lancet 1982; 1: 787–788
- Strom M, Bodemar G, Lindhagen J, Sjödahl R, Walan A. Lancet 1984; 2: 894–897
- Graffner H, Gülich T, Oscarson J. Scand J Gastroenterol 1983; 18: 439–441
- Fry I. Br Med J 1964; 2: 809